Established in 2009 and headquarted in Chengdu High-tech district China, Chengdu Easton Biopharmaceuticals Co., Ltd.(hereinafter referred to as"Easton" or "Easton Biopharma") is a new leading pharmaceutical company, engaging in development, manufacturing and distribution of commercial-scale Finished Dosage Forms (FDFs) and Active Pharmaceutical Ingredients (APIs). Our manufacturing facilities are fully compliant with EU-GMP and US-GMP standards.
Easton Biopharma owns five wholly-funded subsidaries:
Sichuan Sunheal Pharmaceutical Co.,Ltd.
Sichuan Qingmu Pharmaceutical Co.,Ltd.
Xizang Runhe Pharmaceutical Co.,Ltd.
Chengdu Shuode Pharmaceutical Co.,Ltd.
Chengdu Unovel Pharmaceutical Co.,Ltd.
Among which: Sichuan Qingmu Pharmaceutical co., ltd. is mainly engaged in the production and operation of API and pharmaceutical intermediates; Sichuan Sunheal Pharmaceutical Co.,Ltd. and Xizang Runhe Pharmaceutical Co.,Ltd. are mainly engaged in the marketing and distribution of FDFs; Chengdu Shuode Pharmaceutical Co.,Ltd. is located in Chengdu Tianfu International Biological City, which is under construction; Chengdu Unovel Pharmaceutical Co.,Ltd. is committed to research and development of biological drugs.
Easton Biopharma implements innovation-driven strategy for achieving sustainable development, with focusing on continuous improvement of R&D system. We are equipped with a scientific R&D platform including QC labs, R&D center and post-doctoral center. We aim to develop and produce novel and generic drugs in the main areas of Diabetics, Cardiovascular, Oncology, Anesthetic, Analgesics and pediatric drugs.
Sticking to the core values of “Sunshine, Value, Innovation and Efficiency”, Easton Biopharma is commited to provide safe and high quality pharmaceutical products for our customers and patients. Welcome to partner with Easton Biopharma! We strive to work together for sustainable development and great success!
